TCM
RPTP

Tekla Capital Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Tekla Capital Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-110,000
Closed -$1.64M – 70
2013
Q3 		$1.64M Buy
+110,000
New +$1.32M 0.18% 56

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Tekla Capital Management's RPTP Position: Q4 2013 in Review

Tekla Capital Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2013, closing a stake of 110,000 shares — an estimated $1.64M sold.

Tekla Capital Management first reported a position in RPTP in Q3 2013 and held it in 1 quarter. The position peaked at $1.64M in Q3 2013. 68 funds tracked by Wall St. Rank hold RPTP as of Q4 2013.

  • Tekla Capital Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Tekla Capital Management sold 110,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2013, an estimated $1.64M.
  • Tekla Capital Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 1 quarter.
  • Tekla Capital Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.64M in Q3 2013.
  • 68 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2013.

Based on Tekla Capital Management's 13F filing for Q4 2013, filed 28 Jan 2014.